Chairs: Jean-Jacques Kiladjian, Ross Levine, Alessandro Vannucchi

Date: Friday 13 - Sunday 17 May 2022
Venue: Budapest Marriott H5tel, Hungary

New insights into the molecular pathogenesis, classification, and management of patients with Myeloproliferative Neoplasms (MPN) have arisen at increasing pace during the past years. This international conference brings together biologists and clinicians to present and discuss new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment.

The field of MPN research is rapidly expanding and consequently treatment options are changing. Clinical and laboratory investigators involved in the care of MPN patients or in research on the biology of these diseases will profit from hearing international leaders present the newest biological, clinical and therapeutic developments in the field.

The format of the scientific programme is deliberately designed to be conducive to close scientific interaction between speakers and registered participants from all over the world.

Posters and Brief Oral Communications:
Registered participants are invited to submit their biology and clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.

Call for abstracts: deadline Sunday 15 March 2020 

This meeting will be valuable to you if you are looking for:

  • A cutting-edge scientific programme – from basic science to clinical and therapeutic applications and perspectives.
  • An emphasis on in-depth scientific discussion
  • Opportunities for informal face-to-face scientific interaction with global authorities in the field.

The meeting will be of interest to:

  • - Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • - Junior scientists and clinicians (MD, PhD)
  • - PhD candidates and clinical residents still in-training

Learning Objectives:

  • To understand the newest discoveries on the molecular pathogenesis of MPN
  • To appreciate recent changes in treatment recommendations for MPN patients including the evolving landscape of approved therapies
  • To gain insight into ongoing clinical trials investigating novel agents for MPN treatment

Topics:

  • Molecular pathogenesis of MPNs
  • Novel MPN therapeutics
  • MPN Initiation and clonal evolution
  • Murine MPN models and pathogenesis/therapeutic studies
  • Molecular pathogenesis and therapy of MPN progression and leukaemic transformation
  • Recent advances in therapeutics
  • Molecular pathogenesis of MPN
  • Novel MPN therapeutics

The program will include:

Plenary Sessions

  • Simultaneous Meet the Experts Sessions
  • Panel Discussions
  • Selected Short Communications
  • Tutored Poster Walks

For further information and to register your place please visit the conference website or email Maude Brunet-Le Comte

External Events

Jan 21
20
27
28
Feb 21
2
13
20
Mar 21
3
10
11
17
May 22
13
January 20th 2021
Selected Myeloma ASH Updates
A summary of ASH that is clinically relevant to myeloma clinics.
Details
January 27th 2021
Post ASH Significant Highlights
The meeting will provide an overview of the most innovative scientific and clinical data presented at the December 2020…
Details
January 28th 2021
7th Translational Research Conference: Myelodyspla…
Chairs: Pierre Fenaux, Uwe Platzbecker, Mikkael Sekeres
Details
February 2nd 2021
Targeted Treatments for Haematological Cancers
This course describes the unique cellular and genetic features of haematological cancers and covers a diverse range of t…
Details
February 13th 2021
National Undergraduate Haematology Conference 2021…
The student-led Haematology Societies at the Universities of Birmingham, Cambridge and Liverpool are holding an online H…
Details
February 20th 2021
FRCPath-1 Revision Course
This is a popular two-day intensive exam-oriented course, targeted towards haematology trainees aiming to sit their FRCP…
Details
March 3rd 2021
Next Generation Sequencing in Lymphoma
This meeting will provide attendees with a useful opportunity to keep up-to-date with changes in lymphoma practice. Suit…
Details
March 10th 2021
UK CLL Forum Annual Scientific Day
The theme of this virtual meeting is: Closer to deciphering disease complexity. Suitable for Consultants, Trainees, Nurs…
Details
March 11th 2021
Symposium on the contributions by the Anthony Nola…
An outstanding symposium for BMT and future of haematological malignancies in innovative cell therapies.
Details
March 11th 2021
BSHT Virtual Scientific Meeting 2021
The BSHT committee have put together an exciting programme offering over seven hours of educational content that will in…
Details
March 17th 2021
UKMF Spring Day
This meeting will focus on the impact of COVID on multiple myeloma management. Suitable for consultants, trainees, nurse…
Details
May 13th 2022
9th Translational Research Conference: Myeloprolif…
Chairs: Jean-Jacques Kiladjian, Ross Levine, Alessandro Vannucchi
Details